Baker Bros. Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $925M | Buy |
|
|||||
|
2025
Q1 | $712M | Hold |
|
|||||
|
2024
Q4 | $787M | Hold |
|
|||||
|
2024
Q3 | $659M | Hold |
|
|||||
|
2024
Q2 | $697M | Buy |
|
|||||
|
2024
Q1 | $793M | Hold |
|
|||||
|
2023
Q4 | $1.34B | Hold |
|
|||||
|
2023
Q3 | $893M | Hold |
|
|||||
|
2023
Q2 | $1.03B | Buy |
|
|||||
|
2023
Q1 | $789M | Buy |
|
|||||
|
2022
Q4 | $667M | Hold |
|
|||||
|
2022
Q3 | $686M | Hold |
|
|||||
|
2022
Q2 | $591M | Buy |
|
|||||
|
2022
Q1 | $1.02B | Hold |
|
|||||
|
2021
Q4 | $978M | Hold |
|
|||||
|
2021
Q3 | $696M | Hold |
|
|||||
|
2021
Q2 | $1.02B | Hold |
|
|||||
|
2021
Q1 | $1.08B | Buy |
|
|||||
|
2020
Q4 | $2.24B | Hold |
|
|||||
|
2020
Q3 | $1.73B | Hold |
|
|||||
|
2020
Q2 | $2.03B | Hold |
|
|||||
|
2020
Q1 | $1.77B | Buy |
|
|||||
|
2019
Q4 | $1.75B | Hold |
|
|||||
|
2019
Q3 | $1.47B | Buy |
|
|||||
|
2019
Q2 | $1.05B | Sell |
|
|||||
|
2019
Q1 | $1.07B | Hold |
|
|||||
|
2018
Q4 | $642M | Buy |
|
|||||
|
2018
Q3 | $590M | Buy |
|
|||||
|
2018
Q2 | $416M | Hold |
|
|||||
|
2018
Q1 | $612M | Hold |
|
|||||
|
2017
Q4 | $820M | Buy |
|
|||||
|
2017
Q3 | $973M | Hold |
|
|||||
|
2017
Q2 | $720M | Hold |
|
|||||
|
2017
Q1 | $888M | Hold |
|
|||||
|
2016
Q4 | $745M | Hold |
|
|||||
|
2016
Q3 | $821M | Buy |
|
|||||
|
2016
Q2 | $796M | Buy |
|
|||||
|
2016
Q1 | $677M | Buy |
|
|||||
|
2015
Q4 | $730M | Hold |
|
|||||
|
2015
Q3 | $677M | Hold |
|
|||||
|
2015
Q2 | $858M | Hold |
|
|||||
|
2015
Q1 | $667M | Hold |
|
|||||
|
2014
Q4 | $650M | Hold |
|
|||||
|
2014
Q3 | $507M | Hold |
|
|||||
|
2014
Q2 | $463M | Hold |
|
|||||
|
2014
Q1 | $498M | Buy |
|
|||||
|
2013
Q4 | $499M | Hold |
|
|||||
|
2013
Q3 | $548M | Hold |
|
|||||
|
2013
Q2 | $362M | Buy |
|